SOPH Stock Summary and Trading Ideas (Sophia Genetics SA - | NASDAQ:SOPH)

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.

As of January 8, 2026, SOPH stock price declined to $4.96 with 82,117 million shares trading.

SOPH has a beta of 1.75, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.21 to the broad based SPY ETF.

SOPH has a market cap of $329.54 million. This is considered a Small Cap stock.

Last quarter Sophia Genetics SA - reported $19 million in Revenue and -$.30 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.10.

In the last 3 years, SOPH traded as high as $7.37 and as low as $1.99.

The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ.

SOPH has outperformed the market in the last year with a price return of +63.4% while the SPY ETF gained +18.4%. SOPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.2% and +7.8%, respectively, while the SPY returned +3.3% and -0.1%, respectively.

SOPH support price is $4.84 and resistance is $5.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.